Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Watching clot-busting drugs work is science in action

Laura Beaty, MD
Conditions
March 24, 2019
Share
Tweet
Share

There is no better place to watch science in action than in the world of medicine. It was discovered in the 1930s that blood, in the presence of a certain streptococcus bacteria, did not clot. The agent formed by the bacteria was isolated and eventually called streptokinase, the first “clot-buster.” Through the decades, pharmaceutical companies created other similar drugs, but the overall use was still fairly infrequent. The early heart attack studies showed mixed results, and we did not yet understand that more heart attacks were caused by clots than by narrowing of arteries. It also took decades of research to understand that the timing of the event to drug was of utmost importance. But, by the 1990s, studies were conclusive to the level of benefit, protocols were developed and the clot-busters were widely used. In early 2000, angioplasty would win the battle of the best treatment option for a heart attack in progress. Regardless, it was an exciting period in medicine to witness the rapid evolution of effective treatment options.

As a young moonlighting physician

As a young moonlighting physician, this science led to one of the more exciting days in my memory. I was in a rural Iowa hospital on a spring weekend in 1998 when a tall man walked in clutching his chest. He was a semi-truck driver and began having chest pain an hour before he stopped. He drove until he saw a sign for a hospital and got off at our exit. He pulled his semi into our small ER parking lot and walked in, sweaty and short of breath, to describe his classic symptoms. His EKG clearly showed he was in the middle of a massive heart attack. Following the protocol, using the thrombolytic drug the emergency room had on hand, I administered the clot-buster and arranged for the helicopter transport to the University of Iowa Hospital. While standing over his bed, as the medicine was going in, I saw a calm look come over his face and heard him exhale with a sigh. I was probably still holding my own breath as I was a third-year resident and the only physician in that small ER, probably the only physician in the entire hospital. I looked at his EKG tracing to see that the ST elevation of his heart attack had completely resolved. It was a powerful moment for both of us. Even though I knew the science, seeing it in action and witnessing the immediacy of his relief with complete resolution on the EKG was still hard for me to fully comprehend. The excitement of the moment slowly passed as I reviewed his vital signs, updated his record and waited for transport.

After he was safely on the helicopter

After he was safely on the helicopter heading to the hospital that could manage his recovery, I would like to say I took a moment to reflect on his life or on my life or on the power of the science that saved him that day. But, no, I remember clearly that I had a drug seeker with a migraine waiting for me in the next bay. She sat in the chair in her dark glasses and proceeded to complain about the semi-truck blocking too many spots in the ER parking lot. While the sound of her voice made my head start to ache, I stuck my hand in my scrub top and locked my fingers around his keys. While I could harness the power of science in an IV to save his life, I laughed silently at the impossible thought of me trying to move that truck. And, I then jumped into the exasperating task at hand of telling this woman why I was not going to give in to her repeated demands for Demerol.

Laura Beaty is a family physician and can be reached at her self-titled site, Laura Beaty MD.

Image credit: Shutterstock.com

Prev

It's time to change the face of lung cancer

March 24, 2019 Kevin 0
…
Next

How to match into dermatology: A medical student shares her success story

March 24, 2019 Kevin 5
…

Tagged as: Cardiology

Post navigation

< Previous Post
It's time to change the face of lung cancer
Next Post >
How to match into dermatology: A medical student shares her success story

ADVERTISEMENT

More by Laura Beaty, MD

  • “I earned it. I’m proud of it. I am a doctor.”

    Laura Beaty, MD

Related Posts

  • Is social media a friend or foe of science?

    Michael Joyce, MD
  • Take politics out of science and medicine

    Anonymous
  • The cost of drugs confounds this gastroenterologist

    Michael Kirsch, MD
  • Fight gun violence with science

    Jamie Coleman, MD
  • Quality measures have gotten ahead of the science of quality measurement

    Peter Ubel, MD
  • Want to dispose of drugs properly? Here’s how.

    Dennis Wichern

More in Conditions

  • The frustrating bureaucracy of getting a vaccine

    Richard A. Lawhern, PhD
  • Healing from the pandemic’s mental toll

    Zamra Amjid, DHSc, MHA
  • The infectious hypothesis of Alzheimer’s disease

    Larry Kaskel, MD
  • The high cost of PCSK9 inhibitors like Repatha

    Larry Kaskel, MD
  • Why non-work stress fuels burnout

    Perrette St. Preux, RN, MScPH
  • Why wellness programs fail health care

    Jodie Green & Kim Downey, PT
  • Most Popular

  • Past Week

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Diagnosing the epidemic of U.S. violence

      Brian Lynch, MD | Physician
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
    • The frustrating bureaucracy of getting a vaccine

      Richard A. Lawhern, PhD | Conditions
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
    • The stoic cure for modern anxiety

      Osmund Agbo, MD | Physician
  • Recent Posts

    • The frustrating bureaucracy of getting a vaccine

      Richard A. Lawhern, PhD | Conditions
    • Who profits from medical malpractice lawsuits?

      Howard Smith, MD | Physician
    • Healing from the pandemic’s mental toll

      Zamra Amjid, DHSc, MHA | Conditions
    • Choosing the right doctor: How patients can take control of their care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The infectious hypothesis of Alzheimer’s disease

      Larry Kaskel, MD | Conditions
    • A pediatrician on the lead contamination crisis

      Eric Fethke, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Diagnosing the epidemic of U.S. violence

      Brian Lynch, MD | Physician
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
    • The frustrating bureaucracy of getting a vaccine

      Richard A. Lawhern, PhD | Conditions
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
    • The stoic cure for modern anxiety

      Osmund Agbo, MD | Physician
  • Recent Posts

    • The frustrating bureaucracy of getting a vaccine

      Richard A. Lawhern, PhD | Conditions
    • Who profits from medical malpractice lawsuits?

      Howard Smith, MD | Physician
    • Healing from the pandemic’s mental toll

      Zamra Amjid, DHSc, MHA | Conditions
    • Choosing the right doctor: How patients can take control of their care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The infectious hypothesis of Alzheimer’s disease

      Larry Kaskel, MD | Conditions
    • A pediatrician on the lead contamination crisis

      Eric Fethke, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Watching clot-busting drugs work is science in action
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...